Elite Pharma Inc (ELTP) 0.2960 $ELTP Direction of Market

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2015 at 6:10 PM

Elite Pharma Inc (ELTP) 0.2960 $ELTP

Direction of Market Influences - Research on PositiveID, Elite Pharmaceuticals, Century Communities and Innerworkings
ACCESSWIRE - Thu Nov 12, 7:25AM CST
NEW YORK, NY / ACCESSWIRE / November 12, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: PositiveID Corp (OTC: PSID), Elite Pharmaceuticals Inc (OTC: ELTP), Century Communities Inc (NYSE: CCS) and Innerworkings Inc (NASDAQ: INWK). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CCS: 18.29 (+0.15), INWK: 7.88 (-0.02)

Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016
GlobeNewswire - Mon Nov 09, 3:37PM CST
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second quarter of its 2016 fiscal year.

Equities Lead Investor Sentiment - Research on Elite Pharmaceuticals, Medical Marijuana, Ekso Bionics Holdings and Pharmacyte Biotech
ACCESSWIRE - Mon Nov 09, 6:45AM CST
NEW YORK, NY / ACCESSWIRE / November 9, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals Inc (OTC: ELTP),Medical Marijuana Inc (PINKSHEETS: MJNA), Ekso Bionics Holdings Inc (OTC: EKSO) and Pharmacyte Biotech Inc (OTC: PMCB). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Penny Stocks Recap for Endeavor IP, Hemp, Elite Pharmaceuticals, Roadships, Eventure Interactive, and KollagenX
PR Newswire - Fri Nov 06, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Endeavor IP (OTCBB: ENIP), Hemp (OTCMKTS: HEMP), Elite Pharmaceuticals (OTCMKTS: ELTP), Roadships (OTCMKTS: TTCM), Eventure Interactive (OTCBB: EVTI), and KollagenX (OTCMKTS: KGNX).

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015
GlobeNewswire - Thu Nov 05, 4:12PM CST
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, announced today that its second quarter financial results will be released on Monday, November 9, 2015. Following the announcement, Elite's management will host a live conference call and webcast on Tuesday, November 10th at 11:00 a.m. EST to review the company's financial and operating results and provide a general business update. Company executives will conduct a question and answer session following their remarks.

Equities Lead Investor Sentiment - Research on PositiveID, Elite Pharmaceuticals, Century Communities and iShares PHLX Semiconductor
ACCESSWIRE - Thu Nov 05, 6:45AM CST
NEW YORK, NY / ACCESSWIRE / November 5, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: PositiveID Corp (OTC: PSID),Elite Pharmaceuticals Inc (OTC: ELTP), Century Communities Inc (NYSE: CCS) and iShares PHLX Semiconductor ETF (NASDAQ: SOXX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CCS: 18.29 (+0.15), SOXX: 87.10 (-0.79)

Penny Stocks Recap for EKSO BIONICS, Hemp, Agrieuro, GLOBAL DIGITAL SOLTN, Urban Barns Foods, and Elite Pharmaceuticals
PR Newswire - Wed Nov 04, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: EKSO BIONICS (OTCBB:EKSO), Hemp (OTCMKTS:HEMP), Agrieuro (OTCBB:EURI), GLOBAL DIGITAL SOLTN (OTCMKTS:GDSI), Urban Barns Foods (OTCMKTS:URBF), and Elite Pharmaceuticals (OTCMKTS:ELTP).

Direction of Market Influences - Research on Pharmacyte Biotech, NuGene International, Rainbow Coral Corp and Elite Pharmaceuticals
ACCESSWIRE - Mon Nov 02, 7:40AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Pharmacyte Biotech Inc (OTC: PMCB), NuGene International Inc (OTC: NUGN), Rainbow Coral Corp (OTC: RBCC) and Elite Pharmaceuticals Inc (OTC: ELTP). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.

The Reason It Trades, Quarterly Results, Project Financing and Strategic Acquisitions - Research on Dominovas Energy, Priority Aviation, Elite Pharmaceuticals, PositiveID
ACCESSWIRE - Thu Oct 29, 7:01AM CDT
NEW YORK, NY / ACCESSWIRE / October 29, 2015 / Moments ago, Trader's Choice released another issue of its world-class newsletter in which it took the time to review and explain some of the most talked about situations on wall street today: Dominovas Energy Corporation (OTC: DNRG), Priority Aviation, Inc. (OTC: PJET) Elite Pharmaceuticals Inc. (OTC: ELTP) and PositiveID Corporation (OTC: PSID).

Penny Stocks Alerts for Elite Pharmaceuticals, Guided Therapeutics, PositiveID, EKSO BIONICS, ANAVEX LIFE SCIENCES, and Dominovas Energy
PR Newswire - Wed Oct 28, 8:00AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Elite Pharmaceuticals (OTCMKTS:ELTP), Guided Therapeutics (OTCBB:GTHP), PositiveID (OTCMKTS

SID), EKSO BIONICS (OTCBB:EKSO), ANAVEX LIFE SCIENCES (OTCMKTS:AVXLD), and Dominovas Energy (OTCMKTS

NRG).

Be On Top Of the Latest Developments - Research on Elite Pharmaceuticals, NanoTech Entertainment, Medbox and Bioelectronics
ACCESSWIRE - Wed Oct 28, 7:00AM CDT
NEW YORK, NY / ACCESSWIRE / October 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals Inc. (OTC: ELTP), NanoTech Entertainment, Inc. (OTC: NTEK), Medbox Inc. (OTC: MDBX) and Bioelectronics Corp. (OTC: BIEL). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.

Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200
GlobeNewswire - Wed Oct 21, 7:00AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCBB:ELTP) today announced positive top-line results from the Phase 3 pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of moderate to severe pain.

Elite Pharmaceuticals collects record revenues of USD7.1m for Q1 fiscal 2016
M2 - Tue Aug 11, 4:52AM CDT
Pharmaceutical company Elite Pharmaceuticals (OTCBB:ELTP) disclosed on Monday that it recorded consolidated revenues of USD7.1m for the quarter ended 30 June 2015, the first quarter of its 2016 fiscal year.

Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016
GlobeNewswire - Mon Aug 10, 3:20PM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCBB:ELTP), announced results for the quarter ended June 30, 2015, the first quarter of its 2016 fiscal year.

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 1st Quarter 2016 Financial Results on August 11, 2015
GlobeNewswire - Thu Aug 06, 7:00AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, announced today that its first quarter financial results will be released on Monday, August 10, 2015. Following the announcement, Elite's management will host a live conference call and webcast on Tuesday, August 11 at 11:00 a.m. Eastern Daylight Time to review the company's financial and operating results and provide a general business update. Company executives will conduct a question and answer session following their remarks.

Elite Pharmaceuticals Completes Enrollment and Dosing for ELI-200 Phase III Efficacy Trial
GlobeNewswire - Mon Aug 03, 7:00AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCQB:ELTP), today announced the completion of patient enrollment and dosing for the Phase III efficacy trial for ELI-200, an abuse-deterrent opioid product. This Phase III trial is designed to evaluate the efficacy and safety of abuse deterrent ELI-200 for the treatment of adults with moderate to severe pain following surgery. The study enrolled 163 patients at five clinical sites. Top-line efficacy and safety data from this study are expected to be announced near year's end. Submission of the NDA for ELI-200 is also expected shortly thereafter. "I am very pleased that we have completed enrollment, surgeries and dosing for Elite's Phase III trial for ELI-200," stated Nasrat Hakim, President and Chief Executive Officer of Elite. "We expect the NDA submission for ELI-200 near year's end, and in preparation for an ELI-200 launch in 2016, we are expanding our facility and working with our sales partner, Epic Pharma, on pre-launch activities."

Elite Pharmaceuticals awarded new US patent for abuse deterrent technology
M2 - Wed Jun 17, 4:25AM CDT
Pharmaceutical company Elite Pharmaceutical (OTCBB:ELTP) reported on Tuesday the receipt of the US Patent entitled "Abuse-Resistant Oral Dosage Forms" for its opioid abuse deterrent technology.

Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jun 16, 7:50PM CDT

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
GlobeNewswire - Tue Jun 16, 9:33AM CDT
Elite Pharmaceuticals, Inc. ("Elite" or the "Company"

(OTCBB:ELTP) announced today the issuance of U.S. Patent No. 9,056,054 entitled "Abuse-Resistant Oral Dosage Forms". This patent expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.

Elite Pharmaceuticals posts 9% higher record consolidated revenues for fiscal 2015
M2 - Tue Jun 16, 5:58AM CDT
Pharmaceutical company Elite Pharmaceuticals (OTCBB:ELTP) stated on Monday it recorded consolidated revenues of USD5.015m for the fiscal year ended 31 March 2015 (fiscal 2015).

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

St. Croix Financial Hub: Game Changer or Fluff?

You know, sometimes it feels like the financial world gets more tangled than a fishing line on a windy beach. This latest spiel coming out of St. Croix with all its big names and lofty promises—Governor Bryan’s 3rd Wall Street Financial District Hub Initiative—seems like one of those, but maybe it’s got more meat than hype. Half the pitch sounds like your typical...

Ecopetrol Ushers New Executive Leadership for Transition

New Blood Steering the Energy Transition Let's crack open the vault on Ecopetrol's recent maneuver: Armando José Cuello Navarro is stepping up as the new Executive Vice President of Energy Transition. It's like handing the wheel to a seasoned driver in a storm—this guy’s got the chops to navigate Colombia's energy maze. Cuello's resume reads like a textbook on energy...

Clarivate Taps Global Appetite for AI Research Tools

A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...

York Space Systems Faces Critical Lawsuit Deadline

Turbulence in the Satellite Markets When York Space Systems launched its flashy IPO earlier this year, investors lined up in droves, eyes gleaming at the promise of satellite-driven riches. But now, it feels like that promising start shattered faster than a cheap rocket. York, known for its bread-and-butter reliance on federal contracts, primarily with the U.S. Department...

Humanoid Robot SKYE Draws Crowds at NAEC 2026

SKYE Steals the Show at NAEC 2026 You roll into a trade show expecting the usual business cards and hors d'oeuvres. Instead, you stumble into a scene that feels like you've stepped into a sci-fi flick. That's what folks experienced at the National Association of Elevator Contractors (NAEC) 2026 Convention, where Metropolis Robotics unleashed SKYE, a full-size humanoid...

Pearson Targets 2026 Growth with Strategic Moves

Pearson's Q3 Performance: Crunch Time Checking the rearview mirror at Pearson's nine-month journey into 2026, it's quite the sight. Q3 revved up with a 6% growth spurt, aligning neatly with market expectations. Ain't that a relief in today's rocky terrain of education and assessment? Holding a tight rein, they're on course to meet the mid-single digit revenue growth they...

Annual Flu Shots May Save Lives: Accordia Health's Call

Flu Season Isn't Just Sniffles: Accordia Health Speaks Up Listen up folks, it’s that time again and no, it ain’t just about digging out last year's scarf. Flu season is rolling in faster than a train outta hell, and already folks are talking about flu cases creeping up during the summer sunshine. We got Dr. Cameron Kilpatrick over at Accordia Health ringing the bell...

NUH Reinvents Healthcare with Green Innovations

Award-Winning Green Healthcare from NUH The National University Hospital (NUH) in Singapore is making waves and cleaning the air at the same time. It's racked up a shiny Gold Award at the 2026 International Hospital Federation (IHF) Awards for its Green Operating Theatre programme — and folks, it's not just any old clap on the back. This is low-carbon healthcare in...

Longitude Health Strengthens Ranks with Chris Shea Hire

New Leadership for Longitude Health's Legal Team Longitude Health's recent appointment of Chris Shea as Chief Legal and Administrative Officer might not make immediate waves in stock circles, but if you've been paying attention to healthcare's convoluted growth dance, you'd see the stakes. Shea's been knee-deep in the nitty-gritty of the health system labyrinth for more...

Blokees Unveils 900+ Toys at China Expo, Eyes Growth

Toy Titans and Strategic Prowess Swinging into Shanghai with the enthusiasm of a kid in a candy store, Blokees laid out a dazzling array of over 900 products at the 2026 China Toy Expo. Showing off its model kits and BLOKEES WHEELS, it's clear the company's firing on all cylinders, hell-bent on driving competitiveness like a rookie trying to prove their worth in a...